Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.23 | 0.0001 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |